Bird Rock Bio’s novel antibody discovery platform (intramembranous Confirmation Antigen Presenting System)
was developed internally and led to the discovery of nimacimab. iCAPs is a platform that isolates G-protein coupled
receptors (GPCRs) in therapeutically relevant, stable conformations with minimal modifications to the GPCR protein.
Our Pipeline
NEXT ERA OF BIOLOGIC THERAPEUTICS